Heparin resistance induced by intravenous nitroglycerin. A word of caution when both drugs are used concomitantly.
Intravenous (IV) nitroglycerin was found to interfere with the anticoagulant effect of heparin during eight infusions of both drugs in seven patients who were closely monitored with frequent activated partial thromboplastin time determinations. All patients were resistant to heparin when receiving IV nitroglycerin and had a marked increase in sensitivity when discontinuing the IV nitroglycerin therapy. This effect was present whether or not propylene glycol was in the preparation. Patients treated with simultaneous IV nitroglycerin and IV heparin must be monitored often to avoid inadequate anticoagulation, and heparin dosage should be decreased when stopping IV nitroglycerin therapy to avoid hemorrhage.
D000328:Adult; D003327:Coronary Disease / Q000188:drug therapy; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006494:Heparin Antagonists; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000494:pharmacology* / Q000627:therapeutic use; D010314:Partial Thromboplastin Time; D019946:Propylene Glycol; D011409:Propylene Glycols / Q000494:pharmacology; D011446:Prospective Studies
D006494:Heparin Antagonists; D011409:Propylene Glycols; D019946:Propylene Glycol; D006493:Heparin; D005996:Nitroglycerin